ArticleFrontiers in chemistry2024
Hybrid Pd
Article in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- NbRSC advances · 2026Article
- Nano-NiCoRSC advances · 2026Article
- Iron ore pellets based-AgFrontiers in chemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the fabrication of a novel spinel-type Pd₀.₁Cu₀.₉Co₂O₄ nano-flake material designed for Mizoroki-Heck and Suzuki coupling-cum-transesterification reactions. The Pd₀.₁Cu₀.₉Co₂O₄ material was synthesized using a simple co-precipitation method, and its crystalline phase and morphology were characterized through powder XRD, UV-Vis, FESEM, and EDX studies. This material demonstrated excellent catalytic activity in Mizoroki-Heck and Suzuki cross-coupling reactions, performed in the presence of a mild base (K₂CO₃), ethanol as the solvent, and microwave irradiation under ligand-free conditions. Notably, the Heck coupling of acrylic esters proceeded concurrently with transesterification using various alcohols as solvents. The catalyst exhibited remarkable stability under reaction conditions and could be recycled and reused up to ten times while maintaining its catalytic integrity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.